Given the important role played by ROS in the development of non-alcoholic fatty liver disease and hepatocellular carcinoma, it is very likely that liver cell TRPM2 channels, activated by ROS, are involved (reviewed in [1,10]). Here, TRPM2 is linked to hepatocellular carcinoma.